Showing results (521-530 of 532) with videos related to
Sort By:
Pageof 54
Advanced Materials Interfaces|November 15, 2021
CuInS2 Quantum Dot and Polydimethylsiloxane Nanocomposites for All-Optical Ultrasound and Photoacoustic ImagingSemyon Bodian, Richard J Colchester, Thomas J Macdonald, et al.Journal of Youth and Adolescence|October 11, 2023
Reciprocal Associations Between Science Efficacy, STEM Identity and Scientist Career Interest Among Adolescent Girls within the Context of Informal Science LearningMengya Zhao, Emine Ozturk, Fidelia Law, et al.Journal of Youth and Adolescence|February 28, 2024
Developmental Trajectories of Adolescents' Math Motivation: The Role of Mindset and Perceptions of Informal STEM Learning Site InclusivityEmine Ozturk, Mengya Zhao, Adam J Hoffman, et al.Vascular Medicine (London, England)|October 16, 2023
Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteriesHans van Overhagen, Masato Nakamura, Patrick J Geraghty, et al.Lancet (London, England)|December 9, 2008
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trialM F Gomes, M A Faiz, J O Gyapong, et al.Proceedings of the National Academy of Sciences of the United States of America|May 10, 2007
Impacts of Hurricanes Katrina and Rita on the microbial landscape of the New Orleans areaC D Sinigalliano, M L Gidley, T Shibata, et al.Annals of the Rheumatic Diseases|May 21, 2013
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatmentRebeccah J Mathews, James I Robinson, Michele Battellino, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2020
Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritisChenzhi Jing, Tomas Castro-Dopico, Nathan Richoz, et al.Nature Medicine|September 7, 2023
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trialMitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.Research Square|March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's DiseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.Pageof 54